ARCHIVES

2,000 Breast Cancer Recurrence Biomarker Candidates Discovered

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001

Minority CCOP Applications Not Yet Reviewed

December 15, 1989

Senate Kills Plan to Increase Tax On Higher Tar, Nicotine Cigarettes

August 13, 1976

NCI Directory Delayed

January 27, 1984

Reinventing NCI: clinical Trials report Calls for Study Section, increased Funding For Cooperative Groups

October 3, 1997

Four New Centers To Compete In ’84, DeVita Tells Pane

December 16, 1983